Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide

AIDS

Volumn 22, Issue 10, 2008, Pages 1232-1234

  Stary, Georg ^a   Kohrgruber, Norbert ^a   Herneth, Andreas M ^b   Gaiger, Alexander ^b   Stingl, Georg ^a   Rieger, Armin ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; EFAVIRENZ; LAMIVUDINE; RITUXIMAB; THALIDOMIDE; ZIDOVUDINE; IMMUNOLOGIC FACTOR; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ABSENCE OF SIDE EFFECTS; ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LETTER; LOW DRUG DOSE; LYMPH NODE BIOPSY; MALE; MULTIPLE CANCER; MULTIPLE CYCLE TREATMENT; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REMISSION; VENOUS THROMBOEMBOLISM; MIDDLE AGED;

ANTIBODIES, MONOCLONAL; GIANT LYMPH NODE HYPERPLASIA; HIV INFECTIONS; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; THALIDOMIDE;

EID: 50949134561     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282fa75ce     Document Type: Letter

References (10)

1. Waterston A, Bower M. Fifty years of multicentric Castleman's disease. Acta Oncol 2004; 43:698-704.
2. Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, et al. Long-term remission of Kaposi sarcomaassociated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 2001; 98:3473-3475.
3. Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, et al. Humanized antiinterleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 2005; 106:2627-2632.
4. Aaron L, Lidove O, Yousry C, Roudiere L, Dupont B, Viard JP. Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: the impact of highly active antiretroviral therapy. Clin Infect Dis 2002; 35:880-882.
5. Casper C, Nichols WG, Huang ML, Corey L, Wald A. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 2004; 103:1632-1634.
6. Jung CP, Emmerich B, Goebel FD, Bogner JR. Successful treatment of a patient with HIV-associated multicentric Castleman disease (MCD) with thalidomide. Am J Hematol 2004; 75:176-177.
7. Ganti AK, Pipinos I, Culcea E, Armitage JO, Tarantolo S. Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome. Am J Hematol 2005; 79:206-210.
8. Berezne A, Agbalika F, Oksenhendler E. Failure of cidofovir in HIV-associated multicentric Castleman disease. Blood 2004; 103:4368-4369; [author reply 4369].
9. Neuville S, Agbalika F, Rabian C, Briere J, Molina JM. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease. Am J Hematol 2005; 79:337-339.
10. Li J, Luo SK, Xiong WJ, Zhou ZH. Combination of thalidomide and rituximab in suppressing myeloma cells in vitro. Ai Zheng 2002; 21:1324-1327.